The DAHANCA 32 study: Electrochemotherapy for recurrent mucosal head and neck cancer
- 15 December 2018
- journal article
- research article
- Published by Wiley in Head & Neck
- Vol. 41 (2) , 329-339
Abstract
Background: Electrochemotherapy is an established treatment for cutaneous tumors. This study aimed at determining efficacy of electrochemotherapy in recurrent head and neck cancer.Methods: Phase II clinical trial in patients with recurrent head and neck carcinomas with no curative treatment options. Electrochemotherapy was performed under general anesthesia. Primary endpoint was tumor response (CT scanning) evaluated at week 8. Secondary endpoints included biopsy results, MRI and fluorodeoxyglucose‐positron emission tomography scanning, safety, toxicity, pain score, and quality‐of‐life questionnaires.Results: Of 26 patients treated, 5 (19%) achieved complete response, 10 (39%) partial response, resulting in an objective response of 58%. Two responders remain without recurrence. No serious adverse events occurred during treatment. Four events occurred posttreatment: one bleeding episode, two episodes with mucosal swelling, and one patient died due to disease progression.Conclusion: Electrochemotherapy is efficient against local recurrence of head and neck cancer with an overall response rate of 58%.Keywords
Funding Information
- Kræftens Bekæmpelse (R110‐A6996)
This publication has 31 references indexed in Scilit:
- Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trialThe Lancet Oncology, 2013
- Electroporation therapy for T1 and T2 oral tongue cancerActa Oto-Laryngologica, 2010
- From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid TumorsJournal of Nuclear Medicine, 2009
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)European Journal of Cancer, 2009
- Randomized Phase III Evaluation of Cisplatin Plus Fluorouracil Versus Cisplatin Plus Paclitaxel in Advanced Head and Neck Cancer (E1395): An Intergroup Trial of the Eastern Cooperative Oncology GroupJournal of Clinical Oncology, 2005
- Hypopharyngeal Squamous Cell Carcinoma: Treatment Results in 138 Consecutively Admitted PatientsActa Oncologica, 2000
- Bleomycin: Revival of an old drugGeneral Pharmacology: The Vascular System, 1996
- The European Organization for Research and Treatment of Cancer QLQ-C30: A Quality-of-Life Instrument for Use in International Clinical Trials in OncologyJNCI: Journal of the National Cancer Institute, 1993
- Electrochemotherapy potentiation of antitumour effect of bleomycin by local electric pulsesEuropean Journal of Cancer and Clinical Oncology, 1991
- Optimal two-stage designs for phase II clinical trialsControlled Clinical Trials, 1989